CNTA
Centessa Pharmaceuticals
CNTA
CNTA
129 hedge funds and large institutions have $1.8B invested in Centessa Pharmaceuticals in 2025 Q1 according to their latest regulatory filings, with 31 funds opening new positions, 42 increasing their positions, 38 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
0.57% less ownership
Funds ownership: 94.36% → 93.79% (-0.57%)
14% less capital invested
Capital invested by funds: $2.08B → $1.8B (-$286M)
80% less call options, than puts
Call options by funds: $2.37M | Put options by funds: $11.7M
Holders
129
Holding in Top 10
14
Calls
$2.37M
Puts
$11.7M
Top Buyers
| 1 | +$58.2M | |
| 2 | +$32.4M | |
| 3 | +$26.4M | |
| 4 |
Janus Henderson Group
London,
United Kingdom
|
+$14.8M |
| 5 |
Morgan Stanley
New York
|
+$14.6M |
Top Sellers
| 1 | -$65.9M | |
| 2 | -$47.6M | |
| 3 | -$23.9M | |
| 4 |
DTC
Deep Track Capital
Greenwich,
Connecticut
|
-$22.6M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
-$16.4M |